webinar register page

Webinar banner
Assessing the Impact of COVID-19 in Rheumatology: One Year On
The global pandemic has greatly impacted clinical practice and influenced the way patients are managed. Over the past year, our knowledge and understanding of SARS-CoV-2 has greatly improved, with vast amounts of research exploring the effects of COVID-19 and potential treatments and vaccines. This webinar aims to review the impact of COVID-19 – one year on. Here, our faculty will discuss the current data available and the influence of COVID-19 on the management of people with rheumatic diseases and discuss the impact and development of potential vaccines.

Chaired by Prof Iain McInnes, CBE the webinar will cover the following topics:

Treating COVID-19 – Options and Outcomes - Professor John Beigel
Vaccines for COVID-19 - Professor Kevin Winthrop
Managing Patients during COVID-19 Pandemic - Professor Rieke Alten

Apr 8, 2021 05:00 PM in London

Webinar logo
* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Dr John Beigel
Associate Director for Clinical Research @National Institute of Allergy and Infectious Diseases (NIAID), USA
Dr John Beigel is at the US National Institute of Allergy and Infectious Diseases (NIAID). He attended the Medical College of Ohio, complete residency at the University of Cincinnati, a fellowship in Critical Care Medicine at the National Institutes of Health and a fellowship in Infectious Disease at the Massachusetts General Hospital. He has been at the NIH since 2000 (except for one year venture in the biotechnology industry). His research interests are primarily focused on clinical research and therapeutics in influenza and other emerging infectious diseases. He has led a portfolio of several multi-center international, IND treatment studies for influenza (including plasma therapy and combination antivirals), and most recently has helped lead NIAID’s Adaptive COVID-19 Treatment Trial (ACTT) for advancing therapeutics for COVID-19. His current position is Associate Director for Clinical Research within NIAID’s Division of Microbiology and Infectious Diseases.
Professor Kevin Winthrop
Professor of Infectious Diseases, Public Health and Preventive Medicine, and Ophthalmology @Oregon Health and Science University, Oregon, USA
Professor Kevin Winthrop received his undergraduate degree in biology from Yale University and completed his MD degree at Oregon Health Sciences University in Portland, Oregon, USA. He obtained a masters degree in epidemiology at University California at Berkeley and completed an infectious disease epidemiology fellowship with the US Centers for Disease Control and Prevention (CDC) before serving as a staff member at CDC. He has co-authored more than 100 publications, many detailing epidemiologic and clinical aspects of infections and other adverse events associated with immune-mediated inflammatory diseases, particularly those related to biologic immunosuppressive therapies. Professor Winthrop also serves on the editorial board of Annals of Rheumatic Diseases, as Section Editor of Current Rheumatology Reports, and as an Associate Editor of BMC Infectious Diseases.
Professor Rieke Alten
Head of Department of Internal Medicine, Rheumatology @Schlosspark-Klinik, University Medicine Berlin, Germany
Dr Rieke Alten is head of the department of internal Medicine, Rheumatology, Clinical Immunology, Osteology at Schlosspark-Klinik at University Medicine Berlin, where she also serves as the director of the Rheumatology Research Centre. She is a member of the Global Alliance for Patient Access and OMERACT Steering Committee of the Flare in Rheumatoid Arthritis Group. Dr Alten has served as a board member on many occasions for; German Medical Association, the institute for approval of drugs for the German Ministry of Health, “Kaiser-Friedrich-Stiftung” for postgraduate education in Germany and board member of the German Society of Rheumatology.